Brokerages Expect Zoetis Inc (ZTS) to Announce $0.66 Earnings Per Share
Wall Street brokerages expect that Zoetis Inc (NYSE:ZTS) will post earnings per share (EPS) of $0.66 for the current fiscal quarter, according to Zacks Investment Research. Five analysts have provided estimates for Zoetis’ earnings. The lowest EPS estimate is $0.65 and the highest is $0.69. Zoetis reported earnings per share of $0.47 during the same quarter last year, which would suggest a positive year-over-year growth rate of 40.4%. The company is expected to report its next quarterly earnings report before the market opens on Thursday, February 15th.
On average, analysts expect that Zoetis will report full-year earnings of $2.37 per share for the current financial year, with EPS estimates ranging from $2.34 to $2.40. For the next year, analysts expect that the firm will post earnings of $2.81 per share, with EPS estimates ranging from $2.69 to $3.06. Zacks Investment Research’s EPS averages are an average based on a survey of sell-side analysts that cover Zoetis.
Zoetis (NYSE:ZTS) last announced its quarterly earnings data on Thursday, November 2nd. The company reported $0.65 earnings per share for the quarter, topping analysts’ consensus estimates of $0.63 by $0.02. Zoetis had a net margin of 18.29% and a return on equity of 62.39%. The company had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.32 billion. During the same period in the previous year, the business earned $0.52 EPS. The firm’s revenue for the quarter was up 8.5% on a year-over-year basis.
Several hedge funds have recently modified their holdings of ZTS. Northwestern Mutual Wealth Management Co. grew its position in shares of Zoetis by 16.8% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,598 shares of the company’s stock valued at $100,000 after acquiring an additional 230 shares during the period. Steward Partners Investment Advisory LLC bought a new stake in shares of Zoetis during the 3rd quarter valued at $114,000. Harfst & Associates Inc. grew its position in shares of Zoetis by 16.1% during the 2nd quarter. Harfst & Associates Inc. now owns 1,878 shares of the company’s stock valued at $117,000 after acquiring an additional 260 shares during the period. Mitsubishi UFJ Securities Holdings Co. Ltd. grew its position in shares of Zoetis by 251.9% during the 3rd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 1,900 shares of the company’s stock valued at $121,000 after acquiring an additional 1,360 shares during the period. Finally, Shine Investment Advisory Services Inc. lifted its stake in shares of Zoetis by 86.5% during the 3rd quarter. Shine Investment Advisory Services Inc. now owns 2,242 shares of the company’s stock valued at $143,000 after buying an additional 1,040 shares in the last quarter. 93.14% of the stock is owned by hedge funds and other institutional investors.
Shares of Zoetis (NYSE:ZTS) traded up $0.80 during midday trading on Monday, reaching $75.39. 1,902,500 shares of the company were exchanged, compared to its average volume of 1,960,000. Zoetis has a 52 week low of $52.00 and a 52 week high of $75.69. The stock has a market cap of $36,740.00, a price-to-earnings ratio of 39.68, a P/E/G ratio of 1.90 and a beta of 1.06. The company has a debt-to-equity ratio of 2.45, a quick ratio of 1.95 and a current ratio of 2.80.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 1st. Stockholders of record on Friday, January 19th will be given a dividend of $0.126 per share. This is an increase from Zoetis’s previous quarterly dividend of $0.11. The ex-dividend date of this dividend is Thursday, January 18th. This represents a $0.50 dividend on an annualized basis and a dividend yield of 0.67%. Zoetis’s payout ratio is presently 22.11%.
COPYRIGHT VIOLATION NOTICE: This piece was first posted by American Banking News and is the sole property of of American Banking News. If you are viewing this piece on another domain, it was illegally copied and reposted in violation of US & international copyright and trademark legislation. The correct version of this piece can be read at https://www.americanbankingnews.com/2018/01/15/brokerages-expect-zoetis-inc-zts-to-announce-0-66-earnings-per-share.html.
Zoetis Company Profile
Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.